Advances in science, new commercial models and shifts in global opportunities are driving major change for people, organisations, governments and NGOs.

Leaders of big pharma are revising their senior teams, injecting transformation capabilities to contain costs, comply with growing regulation and drive innovation, particularly in the supply chain. This is enabling organisations to target populations with unmet needs, creating new patient segments and broadening access to drugs in developing and pharmerging markets.

Geographic shifts are creating cross-border opportunities for high-performing business leaders, scientists and academics. Managing global mobility and accessing emerging talent are priorities for organisations creating leadership pipelines in the evolving global environment.

As a result, from our offices in local markets and sub-regional hubs, we advise clients on where the talent is, what it looks like and how they can attract it. We excel in global teaming and provide the full resources of our firm to all clients, sharing insight and emerging trends.